{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:47:31Z","timestamp":1795034851960,"version":"4.10.2"},"reference-count":60,"publisher":"American Society of Hematology","issue":"12","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral venous sinus thrombosis (CVST) is an uncommon venous thromboembolic event accounting for &amp;lt;1% of strokes resulting in brain parenchymal injuries. JAK2V617F mutation, the most frequent driving mutation of myeloproliferative neoplasms, has been reported to be associated with worse clinical outcomes in patients with CVST. We investigated whether hematopoietic JAK2V617F expression predisposes to specific pathophysiological processes and\/or worse prognosis after CVST. Using an in\u00a0vivo mouse model of CVST, we analyzed clinical, biological, and imaging outcomes in mice with hematopoietic-restricted Jak2V617F expression, compared with wild-type Jak2 mice. In parallel, we studied a human cohort of JAK2V617F-positive or -negative CVST. Early after CVST, mice with hematopoietic Jak2V617F expression had increased adhesion of platelets and neutrophils in cerebral veins located in the vicinity of CVST. On day 1, Jak2V617F mice had a worse outcome characterized by significantly more frequent and severe intracranial hemorrhages (ICHs) and higher mortality rates. Peripheral neutrophil activation was enhanced, as indicated by higher\u00a0circulating platelet\u2013neutrophil aggregates, upregulated CD11b expression, and higher myeloperoxydase plasma level. Concurrently, immunohistological and brain homogenate analysis showed higher neutrophil infiltration and increased blood-brain barrier disruption. Similarly, patients with JAK2V617F-positive CVST tended to present higher thrombotic burden and had significantly higher systemic immune-inflammation index, a systemic thromboinflammatory marker, than patients who were JAK2V617F-negative. In mice with CVST, our study corroborates that Jak2V617F mutation leads to a specific pattern including increased thrombotic burden, ICH, and mortality. The exacerbated thromboinflammatory response, observed both in mice and patients positive for JAK2V617F, could contribute to hemorrhagic complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011692","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T21:16:56Z","timestamp":1708636616000},"page":"3330-3343","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Exacerbation of thromboinflammation by <i>JAK2<\/i>\n                  <i>V617F<\/i> mutation worsens the prognosis of cerebral venous sinus thrombosis"],"prefix":"10.1182","volume":"8","author":[{"given":"Marie-Charlotte","family":"Bourrienne","sequence":"first","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"},{"name":"2Laboratoire d\u2019H\u00e9matologie, AP-HP, H\u00f4pital Bichat-Claude Bernard, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Cam Duchez","sequence":"additional","affiliation":[{"name":"3UNIROUEN, INSERM U1096, Normandie University, Rouen University Hospital, Hemostasis Unit and INSERM CIC-CRB 1404, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-739X","authenticated-orcid":false,"given":"Doroth\u00e9e","family":"Faille","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"},{"name":"2Laboratoire d\u2019H\u00e9matologie, AP-HP, H\u00f4pital Bichat-Claude Bernard, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-0077","authenticated-orcid":false,"given":"Carine","family":"Farkh","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"},{"name":"2Laboratoire d\u2019H\u00e9matologie, AP-HP, H\u00f4pital Bichat-Claude Bernard, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mialitiana","family":"Solo Nomenjanahary","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Inserm, UMRS-1144, Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0912-917X","authenticated-orcid":false,"given":"Juliette","family":"Gay","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"},{"name":"2Laboratoire d\u2019H\u00e9matologie, AP-HP, H\u00f4pital Bichat-Claude Bernard, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-501X","authenticated-orcid":false,"given":"St\u00e9phane","family":"Loyau","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-435X","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Journ\u00e9","sequence":"additional","affiliation":[{"name":"5Universit\u00e9 Paris Cit\u00e9, INSERM UMS34, F\u00e9d\u00e9ration de Recherche en Imagerie Multimodalit\u00e9s, Facult\u00e9 de M\u00e9decine X. Bichat, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Dupont","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Inserm, UMRS-1144, Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Ollivier","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Inserm, UMRS-1144, Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-925X","authenticated-orcid":false,"given":"Jean-Luc","family":"Villeval","sequence":"additional","affiliation":[{"name":"6INSERM U1287, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-6910","authenticated-orcid":false,"given":"Isabelle","family":"Plo","sequence":"additional","affiliation":[{"name":"6INSERM U1287, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Edmond","sequence":"additional","affiliation":[{"name":"6INSERM U1287, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-9247","authenticated-orcid":false,"given":"Martine","family":"Jandrot-Perrus","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9578-9048","authenticated-orcid":false,"given":"Sylvie","family":"Labrouche-Colomer","sequence":"additional","affiliation":[{"name":"7Universit\u00e9 de Bordeaux, INSERM U1034, Biologie des maladies cardio-vasculaires & Laboratoire d\u2019h\u00e9matologie, Centre Hospitalier Universitaire de Bordeaux, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-3905","authenticated-orcid":false,"given":"Bruno","family":"Cassinat","sequence":"additional","affiliation":[{"name":"8Laboratoire de Biologie Cellulaire, AP-HP, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2773-2784","authenticated-orcid":false,"given":"Emmanuelle","family":"Verger","sequence":"additional","affiliation":[{"name":"8Laboratoire de Biologie Cellulaire, AP-HP, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-6312","authenticated-orcid":false,"given":"Jean-Philippe","family":"Desilles","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Inserm, UMRS-1144, Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"},{"name":"9D\u00e9partement de Neuroradiologie interventionnelle, H\u00f4pital Fondation Rothschild, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7428-1760","authenticated-orcid":false,"given":"Beno\u00eet","family":"Ho-Tin-No\u00e9","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Inserm, UMRS-1144, Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Triquenot Bagan","sequence":"additional","affiliation":[{"name":"10Department of Neurology and INSERM CIC-CRB 1404, Rouen University Hospital, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0911-8999","authenticated-orcid":false,"given":"Mika\u00ebl","family":"Mazighi","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Inserm, UMRS-1144, Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie, Paris, France"},{"name":"11D\u00e9partement de Neurologie, AP-HP, H\u00f4pital Lariboisi\u00e8re, FHU NeuroVasc, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Ajzenberg","sequence":"additional","affiliation":[{"name":"1Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne Paris Nord, INSERM UMRS-1148, Laboratory for Vascular Translational Science, Paris, France"},{"name":"2Laboratoire d\u2019H\u00e9matologie, AP-HP, H\u00f4pital Bichat-Claude Bernard, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"2","key":"2024062515202399700_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","article-title":"Cerebral venous thrombosis: an update","volume":"6","author":"Bousser","year":"2007","journal-title":"Lancet Neurol"},{"issue":"8","key":"2024062515202399700_bib2","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.020","article-title":"A\u00a0multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study","volume":"26","author":"Duman","year":"2017","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"4","key":"2024062515202399700_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000057855","article-title":"Long-term prognosis of cerebral vein and dural sinus thrombosis","volume":"13","author":"Ferro","year":"2002","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"2024062515202399700_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"2024062515202399700_bib5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"key":"2024062515202399700_bib6","doi-asserted-by":"crossref","first-page":"753110","DOI":"10.3389\/fneur.2021.753110","article-title":"Cerebral venous thrombosis: clinical, radiological, biological, and etiological characteristics of a French Prospective Cohort (FPCCVT)\u2014comparison with ISCVT Cohort","volume":"12","author":"Triquenot Bagan","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"2024062515202399700_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1538-7836.2012.04719.x","article-title":"The JAK2 V617F mutation in patients with cerebral venous thrombosis","volume":"10","author":"Passamonti","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3-4","key":"2024062515202399700_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000471891","article-title":"Should we screen for Janus kinase 2 V617F mutation in cerebral venous thrombosis?","volume":"44","author":"Lamy","year":"2017","journal-title":"Cerebrovasc Dis"},{"issue":"22","key":"2024062515202399700_bib9","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","article-title":"JAK2V617F mutation for the early diagnosis of Ph\u2212 myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis","volume":"113","author":"Dentali","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2024062515202399700_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/2396987317719364","article-title":"European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European academy of neurology","volume":"2","author":"Ferro","year":"2017","journal-title":"Eur Stroke J"},{"issue":"9","key":"2024062515202399700_bib11","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.110.581223","article-title":"Venous thromboembolic events after cerebral vein thrombosis","volume":"41","author":"Miranda","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"2024062515202399700_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11239-016-1362-3","article-title":"Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events","volume":"42","author":"Lim","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"2","key":"2024062515202399700_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/STROKEAHA.116.015294","article-title":"Venous thrombotic recurrence after cerebral venous thrombosis: a long-term follow-up study","volume":"48","author":"Palazzo","year":"2017","journal-title":"Stroke"},{"issue":"11","key":"2024062515202399700_bib14","first-page":"3292","article-title":"Features of intracranial hemorrhage in cerebral venous thrombosis","volume":"267","author":"Afifi","year":"2020","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"2024062515202399700_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000215942","article-title":"Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis","volume":"28","author":"Ferro","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"2024062515202399700_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2020.09.023","article-title":"Sex-related characteristics of cerebral vein thrombosis: a secondary analysis of a multicenter international cohort study","volume":"196","author":"Porceddu","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"2024062515202399700_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/hemato2020018","article-title":"Can novel insights into the pathogenesis of myeloproliferative neoplasm-related thrombosis inform novel treatment approaches?","volume":"2","author":"Wolach","year":"2021","journal-title":"Hemato"},{"issue":"7","key":"2024062515202399700_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood-2013-10-530832","article-title":"Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm","volume":"124","author":"Lamrani","year":"2014","journal-title":"Blood"},{"issue":"436","key":"2024062515202399700_bib19","doi-asserted-by":"crossref","first-page":"eaan8292","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"2024062515202399700_bib20","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation","volume":"128","author":"Edelmann","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"2024062515202399700_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1182\/bloodadvances.2019000967","article-title":"N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm","volume":"4","author":"Craver","year":"2020","journal-title":"Blood Adv"},{"issue":"13","key":"2024062515202399700_bib22","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2024062515202399700_bib23","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"issue":"13","key":"2024062515202399700_bib24","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2024062515202399700_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacbts.2019.05.013","article-title":"JAK2V617F-mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure","volume":"4","author":"Sano","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"2024062515202399700_bib26","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1038\/s41467-021-26435-0","article-title":"Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils","volume":"12","author":"Kimishima","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"2024062515202399700_bib27","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","article-title":"Macrophage inflammation, erythrophagocytosis and accelerated atherosclerosis in Jak2V617F mice","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"key":"2024062515202399700_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fneur.2018.00882","article-title":"A\u00a0practical score for prediction of outcome after cerebral venous thrombosis","volume":"9","author":"Barboza","year":"2018","journal-title":"Front Neurol"},{"issue":"12","key":"2024062515202399700_bib31","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/jth.12738","article-title":"Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in\u00a0vivo two-photon imaging","volume":"12","author":"Santisakultarm","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2024062515202399700_bib32","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2013-04-498956","article-title":"JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN\u03b1","volume":"122","author":"Hasan","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2024062515202399700_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s12975-021-00898-1","article-title":"A\u00a0novel mouse model for cerebral venous sinus thrombosis","volume":"12","author":"Bourrienne","year":"2021","journal-title":"Transl Stroke Res"},{"issue":"2","key":"2024062515202399700_bib34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/STROKEAHA.114.007834","article-title":"A\u00a0new grading system based on magnetic resonance imaging in a mouse model of subarachnoid hemorrhage","volume":"46","author":"Egashira","year":"2015","journal-title":"Stroke"},{"issue":"11","key":"2024062515202399700_bib35","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.3390\/cancers12113424","article-title":"Quantification of citrullinated histone H3 bound DNA for detection of neutrophil extracellular traps","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"2024062515202399700_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/svn-2020-000362","article-title":"Prognostic value of systemic immune\u2013inflammation index in acute\/subacute patients with cerebral venous sinus thrombosis","volume":"5","author":"Li","year":"2020","journal-title":"Stroke Vasc Neurol"},{"issue":"7","key":"2024062515202399700_bib37","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"2024062515202399700_bib38","first-page":"1911","article-title":"Is JAK2-mutation associated with extensive clot burden in cerebral venous thrombosis","volume":"6","author":"Sales","year":"2021","journal-title":"Ann Clin Case Rep"},{"issue":"3","key":"2024062515202399700_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000079939","article-title":"Cerebral venous infarction: the pathophysiological concept","volume":"18","author":"Schaller","year":"2004","journal-title":"Cerebrovasc Dis"},{"issue":"10","key":"2024062515202399700_bib40","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2024062515202399700_bib41","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.rpth.2023.100060","article-title":"Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation","volume":"7","author":"Guy","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"2024062515202399700_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","article-title":"Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera","volume":"33","author":"Falanga","year":"2005","journal-title":"Exp Hematol"},{"issue":"6","key":"2024062515202399700_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2016-05-718114","article-title":"The role of leukocytes in thrombosis","volume":"128","author":"Swystun","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2024062515202399700_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00441-017-2727-4","article-title":"Platelet\u2013neutrophil interactions as drivers of inflammatory and thrombotic disease","volume":"371","author":"Lisman","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"1","key":"2024062515202399700_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jtha.2023.08.028","article-title":"Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms","volume":"22","author":"Guy","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2024062515202399700_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13578-022-00845-z","article-title":"Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis","volume":"12","author":"Jin","year":"2022","journal-title":"Cell Biosci"},{"issue":"6","key":"2024062515202399700_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/09537104.2015.1064881","article-title":"The role of platelets in the recruitment of leukocytes during vascular disease","volume":"26","author":"Ed Rainger","year":"2015","journal-title":"Platelets"},{"issue":"4","key":"2024062515202399700_bib48","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/STROKEAHA.115.011238","article-title":"Thromboinflammation in stroke brain damage","volume":"47","author":"De Meyer","year":"2016","journal-title":"Stroke"},{"issue":"7","key":"2024062515202399700_bib30","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/STROKEAHA.117.017080","article-title":"Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation","volume":"48","author":"Desilles","year":"2017","journal-title":"Stroke"},{"issue":"6","key":"2024062515202399700_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J\u00a0Cerebr Blood Flow Metab"},{"key":"2024062515202399700_bib49","doi-asserted-by":"crossref","first-page":"833490","DOI":"10.3389\/fimmu.2022.833490","article-title":"Inflammation in cerebral venous thrombosis","volume":"13","author":"Ding","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"2024062515202399700_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2014.03.040","article-title":"Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases","volume":"134","author":"Dentali","year":"2014","journal-title":"Thromb Res"},{"issue":"12","key":"2024062515202399700_bib52","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ajh.26336","article-title":"Cerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases","volume":"96","author":"Gangat","year":"2021","journal-title":"Am J Hematol"},{"issue":"11","key":"2024062515202399700_bib53","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1002\/ajh.23809","article-title":"Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms an European Leukemia Net study","volume":"89","author":"Martinelli","year":"2014","journal-title":"Am J Hematol"},{"issue":"5","key":"2024062515202399700_bib54","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s13760-022-02077-x","article-title":"Characteristics of patients with cerebral sinus venous thrombosis and JAK2 V617F mutation","volume":"123","author":"Simaan","year":"2023","journal-title":"Acta Neurol Belg"},{"issue":"9","key":"2024062515202399700_bib55","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024062515202399700_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2018.195321","article-title":"Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression","volume":"104","author":"Guy","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"2024062515202399700_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood-2012-07-440487","article-title":"JAK2V617F activates Lu\/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1\/Akt pathway","volume":"121","author":"De Grandis","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2024062515202399700_bib58","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1172\/JCI124566","article-title":"Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm","volume":"130","author":"Poisson","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"2024062515202399700_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI94518","article-title":"Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms","volume":"128","author":"Zhao","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"26","key":"2024062515202399700_bib60","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood.2019001163","article-title":"Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells","volume":"134","author":"Mansier","year":"2019","journal-title":"Blood"},{"issue":"6","key":"2024062515202399700_bib61","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.1312148111","article-title":"JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms","volume":"111","author":"Etheridge","year":"2014","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3330\/2232166\/blooda_adv-2023-011692-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3330\/2232166\/blooda_adv-2023-011692-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T15:21:22Z","timestamp":1719328882000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/12\/3330\/515036\/Exacerbation-of-thromboinflammation-by-JAK2V617F"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011692","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}